These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol. Simons LA; Simons J; Parfitt A Med J Aust; 1992 Oct; 157(7):455-9. PubMed ID: 1406395 [TBL] [Abstract][Full Text] [Related]
3. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. Brown G; Albers JJ; Fisher LD; Schaefer SM; Lin JT; Kaplan C; Zhao XQ; Bisson BD; Fitzpatrick VF; Dodge HT N Engl J Med; 1990 Nov; 323(19):1289-98. PubMed ID: 2215615 [TBL] [Abstract][Full Text] [Related]
4. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins]. Kłosiewicz-Latoszek L; Nowicka G; Szostak WB Wiad Lek; 1993 Aug; 46(15-16):581-5. PubMed ID: 7975581 [TBL] [Abstract][Full Text] [Related]
5. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol. Vega GL; Grundy SM JAMA; 1987 Jan; 257(1):33-8. PubMed ID: 3537351 [TBL] [Abstract][Full Text] [Related]
6. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients. Insull W; Davidson MH; Demke DM; Dujovne CA; Eckert SM; Ginsberg D; Goldberg AC; Hodis HN; Hughes TA; Kane JP Atherosclerosis; 1995 Jan; 112(2):223-35. PubMed ID: 7772081 [TBL] [Abstract][Full Text] [Related]
7. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Zambon A; Hokanson JE; Brown BG; Brunzell JD Circulation; 1999 Apr; 99(15):1959-64. PubMed ID: 10208998 [TBL] [Abstract][Full Text] [Related]
8. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia. Malloy MJ; Kane JP; Kunitake ST; Tun P Ann Intern Med; 1987 Nov; 107(5):616-23. PubMed ID: 3662275 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia. Tonstad S; Ose L; Gørbitz C; Harrison EM; de Koning Gans HJ Scand J Clin Lab Invest; 1993 Aug; 53(5):457-63. PubMed ID: 8210967 [TBL] [Abstract][Full Text] [Related]
10. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up. Ojala JP; Helve E; Karjalainen K; Tarkkanen A; Tikkanen MJ Atherosclerosis; 1990 May; 82(1-2):85-95. PubMed ID: 2360923 [TBL] [Abstract][Full Text] [Related]
11. Low-dose colestipol plus probucol for hypercholesterolemia. Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia. Superko HR; Greenland P; Manchester RA; Andreadis NA; Schectman G; West NH; Hunninghake D; Haskell WL; Probstfield JL Am J Cardiol; 1992 Jul; 70(2):135-40. PubMed ID: 1626496 [TBL] [Abstract][Full Text] [Related]
13. The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment. Korhonen T; Hannuksela ML; Seppänen S; Kervinen K; Kesäniemi YA; Savolainen MJ Eur J Clin Pharmacol; 1999 Feb; 54(12):903-10. PubMed ID: 10192749 [TBL] [Abstract][Full Text] [Related]
14. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin. Arca M; Vega GL; Grundy SM JAMA; 1994 Feb; 271(6):453-9. PubMed ID: 8295321 [TBL] [Abstract][Full Text] [Related]
15. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride. Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754 [TBL] [Abstract][Full Text] [Related]
16. Combination drug therapy for familial combined hyperlipidemia. East C; Bilheimer DW; Grundy SM Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029 [TBL] [Abstract][Full Text] [Related]
17. Effects of colestipol alone and in combination with simvastatin on apolipoprotein B metabolism. Gaw A; Packard CJ; Lindsay GM; Murray EF; Griffin BA; Caslake MJ; Colquhoun I; Wheatley DJ; Lorimer AR; Shepherd J Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):236-49. PubMed ID: 8620338 [TBL] [Abstract][Full Text] [Related]
18. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B. Vega GL; East C; Grundy SM Arteriosclerosis; 1989; 9(1 Suppl):I135-44. PubMed ID: 2912427 [TBL] [Abstract][Full Text] [Related]
19. Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia. Bradford RH; Shear CL; Chremos AN; Franklin FA; Nash DT; Hurley DP; Dujovne CA; Pool JL; Schnaper H; Hesney M Am J Med; 1991 Jul; 91(1B):18S-24S. PubMed ID: 1867232 [TBL] [Abstract][Full Text] [Related]
20. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia. Weisweiler P Metabolism; 1989 Mar; 38(3):271-4. PubMed ID: 2918846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]